CrushSCI.com
67.6平均天数
71.5中位天数
3最短天数
126最长天数
712025发文量

Paper Review Records

全部论文审稿周期

16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

32 天

Twenty‐year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I–III breast cancer

作者
Orit Kaidar‐Person; Caroline G. Weltens; Catherine Fortpied; Luc J. E. E. Scheijmans; Carine Y. Kirkove; Volker Budach; Karine Peignaux‐Casasnovas; Mariacarla Valli; Max Peters; Femke van der Leij; Sofia Rivera; Nicola Weidner; Desirée H. J. G. van den Bongard; Claudia Linsenmeier; Roxolyana Abdah‐Bortnyak; Shaymaa Hosni; Eveline Koiter; Antoine M. Engelen; Adinda Baten; Lydia Champezou; Alain Fourquet; Harry G. M. M. Bartelink; Henk Struikmans; Philip M. P. Poortmans; for the European Organization for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups展开收起
作者单位
1. Breast Radiation Unit Sheba Medical Center Ramat Gan Israel; 2. Gray Faculty of Medical and Health Sciences Tel Aviv University Tel Aviv Israel; 3. Department of Radiation Oncology University Hospitals Leuven Leuven Belgium; 4. Laboratory of Experimental Radiation Oncology Katholieke Universiteit te Leuven Leuven Belgium; 5. European Organization for Research and Treatment of Cancer Brussels Belgium; 6. Department of Radiation Oncology Institute Verbeeten Tilburg Netherlands; 7. Department of Radiation Oncology University Hospital Saint Luc Université Catholique de Louvain Brussels Belgium; 8. Department of Radiation Oncology Comprehensive Cancer Center Charite–University Medicine Berlin Corporate Member of Free University of Berlin and Humboldt University of Berlin BE Berlin Germany; 9. Radiation Oncology Vosspalais BE Berlin Germany; 10. Department of Radiation Oncology Centre Georges François Leclerc Dijon France; 11. Department of Radiation Oncology Sant Anna Hospital Como Italy; 12. Department of Radiation Oncology Ospedale Valduce Como Italy; 13. Department of Radiation Oncology Radiotherapiegroep Deventer/Arnhem Netherlands; 14. Department of Radiation Oncology University Medical Centre Utrecht Utrecht Netherlands; 15. Department of Radiation Oncology Gustave Roussy Cancer Centre Villejuif France; 16. Department of Radiation Oncology University Hospital Tübingen Germany; 17. Department of Radiation Oncology Cancer Center Amsterdam Amsterdam University Medical Center University of Amsterdam Amsterdam Netherlands; 18. Department of Radiation Oncology University Hospital Zürich University of Zürich Zürich Switzerland; 19. Department of Radiation Oncology The Joseph Fishman Oncology Center Rambam Health Care Campus Haifa Israel; 20. Nottingham University Hospitals National Health Service Trust Nottingham UK; 21. Department of Radiation Oncology Medisch Spectrum Twente Enschede Netherlands; 22. Department of Radiation Oncology Institut Curie Paris France; 23. Department of Radiation Oncology Netherlands Cancer Institute Amsterdam Netherlands; 24. Department of Radiation Oncology Haaglanden Medical Center the Hague Leidschendam Netherlands; 25. Department of Radiation Oncology Iridium Netwerk Wilrijk‐Antwerp Belgium; 26. Faculty of Medicine and Health Sciences University of Antwerp Wilrijk‐Antwerp Belgium展开收起
PDF源文件 DOI 网页
93 天

Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision‐making

作者
Lucas Kallas‐Silva; Victor Alexandre dos Santos Valsecchi; Ana O. Hoff; Evelin Cavalcante Farias; Rui Monteiro de Barros Maciel; Rachel Riera; Laura Sterian Ward; Lucas Leite Cunha展开收起
作者单位
1. Laboratory of Molecular and Translational Endocrinology, Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo São Paulo Brazil; 2. Evidence‐Based Medicine and Urgent Medicine Unit, Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo São Paulo Brazil; 3. Instituto do Câncer do Estado de São Paulo Faculdade de Medicina da Universidade de São Paulo São Paulo São Paulo Brazil; 4. Hospital Sirio‐Libanes São Paulo Brazil; 5. School of Medical Sciences, University of Campinas‐UNICAMP Campinas São Paulo Brazil; 6. AC Camargo Cancer Center, São Paulo São Paulo São Paulo Brazil展开收起
PDF源文件 DOI 网页
126 天

Nonpharmacologic interventions for managing distress, anxiety, and depression for patients with cancer and their family caregivers: A systematic review and meta‐analysis

作者
Lisa C. Schiess; Lixin L. Song; Sabine Schädelin; Thomas Fürst; Corinne Urech; Christopher R. Friese; Maria C. Katapodi展开收起
作者单位
1. Department of Clinical Research University of Basel Basel Switzerland; 2. School of Nursing University of Texas at San Antonio San Antonio Texas USA; 3. Department of Clinical Research University Hospital Basel Basel Switzerland; 4. University Medical Library Basel University of Basel Basel Switzerland; 5. Department of Obstetrics and Gynecology University Hospital Basel Basel Switzerland; 6. School of Nursing and Rogel Cancer Center University of Michigan Ann Arbor Michigan USA展开收起
PDF源文件 DOI 网页
85 天

Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review

作者
Brittany L. Greene; Jonathan M. Marron展开收起
作者单位
1. Seattle Children’s Research Institute Seattle Washington USA; 2. Department of Pediatrics University of Washington Seattle Washington USA; 3. Department of Pediatrics Harvard Medical School Boston Massachusetts USA; 4. Dana‐Farber/Boston Children’s Cancer and Blood Disorders Center Boston Massachusetts USA; 5. Center for Bioethics Harvard Medical School Boston Massachusetts USA展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿62 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 [email protected]

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。